By Michelle Nichols UNITED NATIONS (Reuters) -The European Commission is helping the United Nations and Turkey try to extend a

Thailand plans to tap Chinese social-media influencers and companies like Huawei Technologies Co. and Alipay to promote the

Using existing drugs to treat cervical cancer before standard treatment could lead to a 35% reduction in the risk of relapse or death, a new study suggests. Researchers from the UCL Cancer Institute and UCLH looked into whether a short course of induction chemotherapy (IC), where a drug is used to destroy as many cancer cells as possible, before chemoradiation (CRT), could help with this. Here’s everything you need to know about the findings… What is cervical cancer? According to the NHS website, cervical cancer is a type of cancer found anywhere near the cervix – the opening between the vagina and the womb (uterus), which is also known as the neck of the womb. Most cervical cancers grow very slowly and are caused by an infection from specific types of human papillomavirus (HPV) and mostly affect women under the age of 45. According to Jo’s Cervical Cancer Trust, symptoms include vaginal bleeding that is unusual to you, changes to vaginal discharge, discomfort during sex and pain in your lower back or pelvis. Changes to cells can be spotted by a cervical screening, and then treated before they turn into cancer. There are around 3,200 new cases every year in the UK, with the five-year survival rate being around 70%, according to Cancer Research UK. CRT has been the standard treatment for cervical cancer patients since 1999, but even though there have been overall significant developments in radiation therapy techniques, up to 30% of people experience their cancer coming back. What did the research involve? Over a 10-year period, 500 patients who had been diagnosed with cervical cancer – that was large enough to see without a microscope but hadn’t spread to other parts of the body – took part in the Interlace trial at hospitals in the UK, Mexico, India, Italy and Brazil. Researchers looked into whether a short course of IC before CRT could reduce rates of relapse and death. What results were found? After five years, researchers discovered that 80% of the people who received a combination of chemotherapy and radiotherapy were alive, whilst 73% had not seen their cancer return or spread. A major benefit, according to researchers, is that it can be incorporated into standard of care treatment relatively quickly, because cheap, accessible and already-approved ingredients such as carboplatin and paclitaxel are needed for IC. “Our trial shows that this short course of additional chemotherapy delivered immediately before the standard CRT can reduce the risk of the cancer returning or death by 35%,” said Dr Mary McCormack, lead investigator of the trial from UCL Cancer Institute and UCLH. “This is the biggest improvement in outcome in this disease in over 20 years. “I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere. “We couldn’t have done this without the generous support of Cancer Research UK.” Why is the research important? Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “Timing is everything when you’re treating cancer. The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial. “A growing body of evidence is showing the value of additional rounds of chemotherapy before other treatments like surgery and radiotherapy in several other cancers. “Not only can it reduce the chances of cancer coming back, it can be delivered quickly using drugs already available worldwide. “We’re excited for the improvements this trial could bring to cervical cancer treatment and hope short courses of induction chemotherapy will be rapidly adopted in the clinic.”

It’s been a wonderful year at the movies for cinephiles, but what do you get for the film lover who has seen everything already

Target and Home Depot are slumping. But more shoppers are heading to Walmart for groceries and essentials.

Indiana's Republican attorney general is facing three professional ethics charges stemming from public statements he made last year about a state doctor he sought to punish for providing abortion services to a 10-year-old Ohio rape victim.

Have you started seeing weird little numbers popping up on people's Instagram profiles? Well, that'll

This content originally appeared on Mashable for a US audience and has been adapted for

Hot dogs and sausages grilled during this year’s US Fourth of July holiday will likely contain a little

New Mexico Gov. Michelle Lujan Grisham’s emergency order suspending the right to carry firearms in public in and around Albuquerque has drawn an immediate court challenge Saturday from a gun-rights group

Australia's kangaroos could die in "catastrophic" numbers if a population boom is left unchecked, ecologists have warned, while backing the...

The Austrian Grand Prix will remain on the Formula One calendar until at least 2030 after a new long-term deal at Spielberg’s Red Bull Ring was confirmed ahead of Sunday’s race. The circuit, which was bought and re-branded by Red Bull founder Dietrich Mateschitz returned to the F1 schedule in 2014 and has been a permanent fixture since. Mateschitz died last year, aged 78, after battling a long-term illness. “The vision and passion of Dietrich Mateschitz, a man who loved this sport, made this all possible and it is a very special moment and a tribute to him that we can confirm we will be racing at this incredible venue until 2030,” said F1 chief executive Stefano Domenicali. The race in Austria is a big favourite for the drivers and all our fans and we are looking forward to many years of excitement and action that are ahead of us.” Red Bull driver Max Verstappen will start on pole position for Sunday’s 71-lap Grand Prix as he bids to extend his 70-point championship lead. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live